Analysts, Shorts Divided on Stemline Therapeutics, Inc. (STML)

Stemline Therapeutics Inc (STML) is a favorite among analysts, but short sellers aren't convinced

Dec 31, 2014 at 2:28 PM
facebook twitter linkedin

A number of biotech stocks are rallying this afternoon, including Stemline Therapeutics Inc (NASDAQ:STML). At last check, shares of the cancer treatment developer are up nearly 9% at $17.22 -- but remain 12.2% lower year-to-date. Meanwhile, a look around Wall Street reveals little in the way of a consensus opinion.

On the one hand, the brokerage bunch is extremely bullish toward STML, with 100% of covering analysts doling out a "strong buy" rating. Additionally, the equity's consensus 12-month price target of $54.60 more than triples the current stock price. Last week, Aegis Capital cut STML's target price by $7 to $68 -- but that still represents a premium of almost 50% to STML's record high of $47.25, touched last October.

On the flip side, short sellers have been betting on downside for STML. Roughly one-tenth of the security's float is sold short, which would take about nine days to buy back, at typical daily trading volumes. In fact, current short interest levels are just a chip-shot away from the all-time peak touched earlier this month.

Looking ahead, Stemline Therapeutics Inc (NASDAQ:STML) is scheduled to make an appearance at the J.P. Morgan Healthcare Conference on Jan. 15 in San Francisco. This event could provide a catalyst, either to the upside or downside. What's more, an ensuing shift in sentiment -- in the form of either bearish brokerage notes or short-covering activity -- could further intensify any such move.


Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 



Special Offers from Schaeffer's Trading Partners